FDA furlough threat
FDAers and other HHS employees have been told to show up for work on Oct. 9 although the threat of furloughs has been revived by the House of Representative's 254 to 179 vote against the budget summit agreement on Oct. 5. On the same day, the government's stopgap omnibus spending bill expired and President Bush said he would not sign another temporary funding bill unless a budget resolution is passed. HHS made preparations to furlough FDAers for about seven days a month in case the Gramm-Rudman law goes into effect, but the agency said it would not do so during the first two weeks of October.
You may also be interested in...
Without the MRA that allows unimpeded bilateral device trade between the EU and Switzerland, Swiss industry is having to find ways of limiting the damage that newly erected barriers will cause after the MDR comes into force.
Amneal is set to benefit from 180 days of US exclusivity for its norelgestromin and ethinyl estradiol contraceptive patch product after receiving FDA approval with a competitive generic therapy designation. The generic will be the only competitor to Mylan’s Xulane version.
Enjoying a 5% sales rise, Bayer Consumer Health grew faster than the global market last year, with the company keen to repeat the performance in 2021.